CRISPR-Based Method Boosts Prostate Cancer Immunotherapy Response

Scientists have developed a CRISPR-based RNA targeting technique that makes prostate cancer cells more identifiable and susceptible to immune system attacks. This experimental approach significantly improved the effectiveness of immunotherapy in mouse models. The findings suggest a promising new strategy for treating challenging tumors, potentially leading to more effective cancer therapies.